TickerFactsScreenerDevelopers

ANAVEX LIFE SCIENCES CORP. (AVXL) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: -$4.59M2011: -$3.80M2012: -$1.69M2013: -$777.6K2014: -$2.66M2015: -$4.23M2016: -$9.24M2017: -$9.02M2018: -$12.58M2019: -$18.53M2020: -$21.29M2021: -$30.38M2022: -$24.24M2023: -$27.79M2024: -$30.81M2025: -$39.04M-$39.04M
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$39.04M-26.7%
2024-$30.81M-10.9%
2023-$27.79M-14.6%
2022-$24.24M+20.2%
2021-$30.38M-42.7%
2020-$21.29M-14.9%
2019-$18.53M-47.2%
2018-$12.58M-39.5%
2017-$9.02M+2.4%
2016-$9.24M-118.5%
2015-$4.23M-58.9%
2014-$2.66M-242.0%
2013-$777.6K+54.1%
2012-$1.69M+55.5%
2011-$3.80M+17.2%
2010-$4.59M—